More opportunities to save on your medicine
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Having trouble viewing this e-mail? View web version
United Therapeutics Now Offers a $10 Co-pay for
Tyvaso® (treprostinil) and Remodulin® (treprostinil)
Now available Still available
Tyvaso®
REMODULIN®
$10 Per CO-PAY
ORENITRAM®
If you are eligible to enroll in this co-pay assistance
program, you may pay only $10 per co-pay
for each medicine, up to a $6000 savings per year.*
. . . . . . . . . . . . . . . . . . . . . . . .
Visit or call for Tyvaso
and Remodulin
enrollment information
www.UTcopay.com
1-800-246-5307
Call ASSIST for information
on Orenitram
co-pay support
1-877-UNITHER
(1-877-864-8437)
*TO ENROLL IN THIS PROGRAM, YOU MUST UNDERSTAND AND AGREE TO COMPLY WITH THE ELIGIBILITY REQUIREMENTS AND TERMS OF USE.
Eligibility Requirements for this program are:
You must be 18 years or older to use this Program
The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication
Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
Eligible patients must be residents of the US or Puerto Rico
Visit www.UTcopay.com for full program details and Terms and Conditions.
Financial assistance options may be available for those who do not qualify for this program. Contact ASSIST for more information.
United Therapeutics
Unither.com | Privacy Policy | Terms of Use
This promotional communication is provided by United Therapeutics.
This message was sent to [email]. If you do not wish to receive e-mails
from United Therapeutics, please click here.
Please do not reply to this e-mail, as this is an unattended e-mail box.
Orenitram, Remodulin, and Tyvaso are registered trademarks of United Therapeutics Corporation.
© 2017 United Therapeutics Corporation. All rights reserved. US/AORT/0008